In specific, PC patients with high SLC1A5 expression had a shorter overall survival (OS) (Figure 1E, Hazard ratio (HR)= 2.02, P=0.0094, log-rank test) or relapse-free survival (Figure 1F, HR = 4.23, P=0.013, log-rank test) than patients with low expression. The gene discussed is SLC1A5; the disease is pachyonychia congenita.